Kayla A. Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kayla A. Johnson has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Arjun Krishnan
Department of Biomedical Informatics, University of Colorado Anschutz , Aurora, CO 80045
9 shared publications - Christopher A. Mancuso
Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz , Aurora, CO 80045
5 shared publications - Renming Liu
Michigan State University
4 shared publications - Aaron Antcliff
College of Medicine, Central Michigan University, Mount Pleasant, MI 48859, USA
2 shared publications - Ajit Sharma
Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, MI 48859, USA
2 shared publications - Anna Yannakopoulos
Dept. of Computational Mathematics, Science and Engineering, Michigan State University. East Lansing, MI, United States
2 shared publications
Latest Publications
- Open Access
Large-scale automated detection reveals pervasive sex imbalance in biomedical research
Sex is a critical biological variable that impacts disease risk, progression, and treatment response across virtually every organ system. However, decades of biomedical research have relied primarily on male study subjects, leaving large gaps in our understanding of female-specific disease biology. Quantifying the extent of this imbalance across thousands of disease areas and millions of publicly available biological samples has remained computationally intractable. Here, we present a multimodal computational framework that infers the biological sex of ∼230,000 publicly available human transcriptome samples and links inferred sex labels to disease terms extracted from ∼9,000 associated study records and ∼5,000 publication abstracts to quantify sex imbalance at scale. Applying this approach revealed that the majority of disease terms with the largest research-derived sex imbalance are skewed toward male representation, including areas with no known biological justification for that imbalance. After adjusting for global sex-specific disease prevalence to isolate biologically unjustified imbalance, up to 58% of all disease terms showed male-leaning association. Diseases including glioblastoma, cirrhosis, idiopathic pulmonary fibrosis, and schizophrenia emerged as critically understudied in females despite affecting both sexes comparably. These findings provide a principled, data-driven basis for prioritizing compensatory research efforts and offer a reusable framework for ongoing monitoring of sex representation in the biomedical literature. Highlights: Skewed male and female study subject representation in biomedical research is the result of decades of studies conducted without adequate female representation. We developed an automated, multimodal framework to estimate the sex imbalance across thousands of disease terms using metadata from ∼230,000 transcriptomics samples and their associated ∼9,000 studies and ∼5,000 publications. Our approach identifies non-sex-specific disease research areas that have been studied using an unbalanced sex demographic. These areas need compensatory and balanced studies to understand sex differences.
Open AccessLarge-scale automated detection reveals pervasive sex imbalance in biomedical research
Sex is a critical biological variable that impacts disease risk, progression, and treatment response across virtually every organ system. However, decades of biomedical research have relied primarily on male study subjects, leaving large gaps in our understanding of female-specific disease biology. Quantifying the extent of this imbalance across thousands of disease areas and millions of publicly available biological samples has remained computationally intractable. Here, we present a multimodal computational framework that infers the biological sex of ∼230,000 publicly available human transcriptome samples and links inferred sex labels to disease terms extracted from ∼9,000 associated study records and ∼5,000 publication abstracts to quantify sex imbalance at scale. Applying this approach revealed that the majority of disease terms with the largest research-derived sex imbalance are skewed toward male representation, including areas with no known biological justification for that imbalance. After adjusting for global sex-specific disease prevalence to isolate biologically unjustified imbalance, up to 58% of all disease terms showed male-leaning association. Diseases including glioblastoma, cirrhosis, idiopathic pulmonary fibrosis, and schizophrenia emerged as critically understudied in females despite affecting both sexes comparably. These findings provide a principled, data-driven basis for prioritizing compensatory research efforts and offer a reusable framework for ongoing monitoring of sex representation in the biomedical literature. Highlights: Skewed male and female study subject representation in biomedical research is the result of decades of studies conducted without adequate female representation. We developed an automated, multimodal framework to estimate the sex imbalance across thousands of disease terms using metadata from ∼230,000 transcriptomics samples and their associated ∼9,000 studies and ∼5,000 publications. Our approach identifies non-sex-specific disease research areas that have been studied using an unbalanced sex demographic. These areas need compensatory and balanced studies to understand sex differences.
- 12 December 2025
- Published by Springer Nature in Nature Methods
- Vol. 23  (2) , 312-327
Computational strategies for cross-species knowledge transfer
Research organisms provide invaluable insights into human biology and diseases, serving as essential tools for functional experiments, disease modeling and drug testing. However, evolutionary divergence between humans and research organisms hinders effective knowledge transfer across species. Here, we review state-of-the-art methods for computationally transferring knowledge across species, primarily focusing on methods that use transcriptome data and/or molecular networks. Our Perspective addresses four key areas: (1) transferring disease and gene annotation knowledge across species, (2) identifying functionally equivalent molecular components, (3) inferring equivalent perturbed genes or gene sets and (4) identifying equivalent cell types. We conclude with an outlook on future directions and several key challenges that remain in cross-species knowledge transfer, including introducing the concept of ‘agnology’ to describe functional equivalence of biological entities, regardless of their evolutionary origins. This concept is becoming pervasive in integrative data-driven models in which evolutionary origins of functions can remain unresolved.
- 12 December 2025
- Published by Springer Nature in Nature Methods
- Vol. 23  (2) , 312-327
Computational strategies for cross-species knowledge transfer
Research organisms provide invaluable insights into human biology and diseases, serving as essential tools for functional experiments, disease modeling and drug testing. However, evolutionary divergence between humans and research organisms hinders effective knowledge transfer across species. Here, we review state-of-the-art methods for computationally transferring knowledge across species, primarily focusing on methods that use transcriptome data and/or molecular networks. Our Perspective addresses four key areas: (1) transferring disease and gene annotation knowledge across species, (2) identifying functionally equivalent molecular components, (3) inferring equivalent perturbed genes or gene sets and (4) identifying equivalent cell types. We conclude with an outlook on future directions and several key challenges that remain in cross-species knowledge transfer, including introducing the concept of ‘agnology’ to describe functional equivalence of biological entities, regardless of their evolutionary origins. This concept is becoming pervasive in integrative data-driven models in which evolutionary origins of functions can remain unresolved.
- Open Access
Annotating publicly-available samples and studies using interpretable modeling of unstructured metadata
Reusing massive collections of publicly available biomedical data can significantly impact knowledge discovery. However, these public samples and studies are typically described using unstructured plain text, hindering the findability and further reuse of the data. To combat this problem, we propose txt2onto 2 . 0 , a general-purpose method based on natural language processing and machine learning for annotating biomedical unstructured metadata to controlled vocabularies of diseases and tissues. Compared to the previous version ( txt2onto 1 . 0 ), which uses numerical embeddings as features, this new version uses words as features, resulting in improved interpretability and performance, especially when few positive training instances are available. Txt2onto 2 . 0 uses embeddings from a large language model during prediction to deal with unseen-yet-relevant words related to each disease and tissue term being predicted from the input text, thereby explaining the basis of every annotation. We demonstrate the generalizability of txt2onto 2 . 0 by accurately predicting disease annotations for studies from independent datasets, using proteomics and clinical trials as examples. Overall, our approach can annotate biomedical text regardless of experimental types or sources. Code, data, and trained models are available at https://github.com/krishnanlab/txt2onto2.0 . Key points: We developed txt2onto 2 . 0 , a computational method that combines language models and machine learning to annotate public samples and studies with standardized tissue and disease terms, with a focus on interpretability and explainability. Txt2onto 2 . 0 uses word/phrase occurrence statistics to represent sample/study metadata, train machine learning models, and predict terms in controlled vocabularies to annotate each sample and study. This approach allows the model to keep track of predictive words related to model decisions and easily separate informative from uninformative words. Txt2onto 2 . 0 outperforms its predecessor, txt2onto 1 . 0 , in tissue and disease annotation, especially when training data is limited. The predictive features learned by txt2onto 2 . 0 are highly interpretable. These features not only include explicit mentions of the actual disease or tissue terms but also related biomedical concepts, including words that are unseen by the model during training. Although trained on metadata of transcriptomes, txt2onto 2 . 0 is capable of annotating disease and tissue for any kind of biomedical metadata, making it a versatile tool for sample and study annotation.
Open AccessAnnotating publicly-available samples and studies using interpretable modeling of unstructured metadata
Reusing massive collections of publicly available biomedical data can significantly impact knowledge discovery. However, these public samples and studies are typically described using unstructured plain text, hindering the findability and further reuse of the data. To combat this problem, we propose txt2onto 2 . 0 , a general-purpose method based on natural language processing and machine learning for annotating biomedical unstructured metadata to controlled vocabularies of diseases and tissues. Compared to the previous version ( txt2onto 1 . 0 ), which uses numerical embeddings as features, this new version uses words as features, resulting in improved interpretability and performance, especially when few positive training instances are available. Txt2onto 2 . 0 uses embeddings from a large language model during prediction to deal with unseen-yet-relevant words related to each disease and tissue term being predicted from the input text, thereby explaining the basis of every annotation. We demonstrate the generalizability of txt2onto 2 . 0 by accurately predicting disease annotations for studies from independent datasets, using proteomics and clinical trials as examples. Overall, our approach can annotate biomedical text regardless of experimental types or sources. Code, data, and trained models are available at https://github.com/krishnanlab/txt2onto2.0 . Key points: We developed txt2onto 2 . 0 , a computational method that combines language models and machine learning to annotate public samples and studies with standardized tissue and disease terms, with a focus on interpretability and explainability. Txt2onto 2 . 0 uses word/phrase occurrence statistics to represent sample/study metadata, train machine learning models, and predict terms in controlled vocabularies to annotate each sample and study. This approach allows the model to keep track of predictive words related to model decisions and easily separate informative from uninformative words. Txt2onto 2 . 0 outperforms its predecessor, txt2onto 1 . 0 , in tissue and disease annotation, especially when training data is limited. The predictive features learned by txt2onto 2 . 0 are highly interpretable. These features not only include explicit mentions of the actual disease or tissue terms but also related biomedical concepts, including words that are unseen by the model during training. Although trained on metadata of transcriptomes, txt2onto 2 . 0 is capable of annotating disease and tissue for any kind of biomedical metadata, making it a versatile tool for sample and study annotation.
- Open Access
- 10 January 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20  (1) , e1011773
Joint representation of molecular networks from multiple species improves gene classification
Network-based machine learning (ML) has the potential for predicting novel genes associated with nearly any health and disease context. However, this approach often uses network information from only the single species under consideration even though networks for most species are noisy and incomplete. While some recent methods have begun addressing this shortcoming by using networks from more than one species, they lack one or more key desirable properties: handling networks from more than two species simultaneously, incorporating many-to-many orthology information, or generating a network representation that is reusable across different types of and newly-defined prediction tasks. Here, we present GenePlexusZoo, a framework that casts molecular networks from multiple species into a single reusable feature space for network-based ML. We demonstrate that this multi-species network representation improves both gene classification within a single species and knowledge-transfer across species, even in cases where the inter-species correspondence is undetectable based on shared orthologous genes. Thus, GenePlexusZoo enables effectively leveraging the high evolutionary molecular, functional, and phenotypic conservation across species to discover novel genes associated with diverse biological contexts.
- 10 January 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20  (1) , e1011773
Open AccessJoint representation of molecular networks from multiple species improves gene classification
Network-based machine learning (ML) has the potential for predicting novel genes associated with nearly any health and disease context. However, this approach often uses network information from only the single species under consideration even though networks for most species are noisy and incomplete. While some recent methods have begun addressing this shortcoming by using networks from more than one species, they lack one or more key desirable properties: handling networks from more than two species simultaneously, incorporating many-to-many orthology information, or generating a network representation that is reusable across different types of and newly-defined prediction tasks. Here, we present GenePlexusZoo, a framework that casts molecular networks from multiple species into a single reusable feature space for network-based ML. We demonstrate that this multi-species network representation improves both gene classification within a single species and knowledge-transfer across species, even in cases where the inter-species correspondence is undetectable based on shared orthologous genes. Thus, GenePlexusZoo enables effectively leveraging the high evolutionary molecular, functional, and phenotypic conservation across species to discover novel genes associated with diverse biological contexts.
- Open Access
Joint representation of molecular networks from multiple species improves gene classification
Network-based machine learning (ML) has the potential for predicting novel genes associated with nearly any health and disease context. However, this approach often uses network information from only the single species under consideration even though networks for most species are noisy and incomplete. While some recent methods have begun addressing this shortcoming by using networks from more than one species, they lack one or more key desirable properties: handling networks from multiple species, incorporating many-to-many orthology information, or generating a network representation that is reusable across different types of and newly-defined prediction tasks. Here, we present GenePlexusZoo, a framework that casts molecular networks from multiple species into a single reusable feature space for network-based ML. We demonstrate that this multi-species network representation improves both gene classification within a single species and knowledge-transfer across species, even in cases where the inter-species correspondence is undetectable based on shared orthologous genes. Thus, GenePlexusZoo enables effectively leveraging the high evolutionary molecular, functional, and phenotypic conservation across species to discover novel genes associated with diverse biological contexts.
Open AccessJoint representation of molecular networks from multiple species improves gene classification
Network-based machine learning (ML) has the potential for predicting novel genes associated with nearly any health and disease context. However, this approach often uses network information from only the single species under consideration even though networks for most species are noisy and incomplete. While some recent methods have begun addressing this shortcoming by using networks from more than one species, they lack one or more key desirable properties: handling networks from multiple species, incorporating many-to-many orthology information, or generating a network representation that is reusable across different types of and newly-defined prediction tasks. Here, we present GenePlexusZoo, a framework that casts molecular networks from multiple species into a single reusable feature space for network-based ML. We demonstrate that this multi-species network representation improves both gene classification within a single species and knowledge-transfer across species, even in cases where the inter-species correspondence is undetectable based on shared orthologous genes. Thus, GenePlexusZoo enables effectively leveraging the high evolutionary molecular, functional, and phenotypic conservation across species to discover novel genes associated with diverse biological contexts.
- Open Access
Human pan-body age- and sex-specific molecular phenomena inferred from public transcriptome data using machine learning
Age and sex are historically understudied factors in biomedical studies even though many complex traits and diseases vary by these factors in their incidence and presentation. As a result, there are massive gaps in our understanding of genes and molecular mechanisms that underlie sex- and age-associated physiology and disease. Hundreds of thousands of publicly-available human transcriptomes capturing gene expression profiles of tissues across the body and subject to various biomedical and clinical factors present an invaluable, yet untapped, opportunity for bridging these gaps. Here, we present a computational framework that leverages these data to infer genome-wide molecular signatures specific to sex and age groups. As the vast majority of these profiles lack age and sex labels, the core idea of our framework is to use the measured expression data to predict missing age/sex metadata and derive the signatures from the predictive models. We first curated ∼30,000 primary samples associated with age and sex information and profiled using microarray and RNA-seq. Then, we used this dataset to infer sex-biased genes within eleven age groups along the human lifespan and then trained machine learning (ML) models to predict these age groups from gene expression values separately within females and males. Specifically, we trained one-vs-rest logistic regression classifiers with elastic-net regularization to classify transcriptomes into age groups. Dataset-level cross validation shows that these ML classifiers are able to discriminate between age groups in a biologically meaningful way in each sex across technologies. Further, these predictive models capture sex-stratified age-group ‘gene signatures’, i.e., the strength and the direction of importance of genes across the genome for each age group in each sex. Enrichment analysis of these gene signatures with prior gene annotations helped in identifying age- and sex-associated multi-tissue and pan-body molecular phenomena (e.g., general immune response, inflammation, metabolism, hormone response). We developed a web-app ( http://mlgenesignatures.org/ ) to visualize our expression dataset, signatures, and enrichment results to make these easily accessible for interested researchers. Overall, we have presented a path for effectively leveraging massive public omics data collections to investigate the molecular basis of age- and sex-differences in physiology and disease. Summary: Hundreds of thousands of publicly-available human transcriptomes capturing gene expression profiles of tissues across the body and subject to various biomedical and clinical factors present an invaluable, yet untapped, opportunity for studying age and sex. We first curated ∼30,000 primary microarray and RNA-seq samples. Then, we used this dataset to infer sex-biased genes within eleven age groups along the human lifespan and trained machine learning models to predict these age groups from gene expression values separately within females and males. These predictive models capture sex-stratified age-group ‘gene signatures’, i.e., the strength and the direction of importance of every gene in each age group in each sex. Enrichment analysis of these gene signatures with prior gene annotations helped identify age- and sex-associated multi-tissue molecular phenomena. A web-app makes our dataset and results easily visualizable. Overall, we have presented a path for effectively leveraging massive public omics data collections to investigate the molecular basis of age- and sex-differences in physiology and disease.
Open AccessHuman pan-body age- and sex-specific molecular phenomena inferred from public transcriptome data using machine learning
Age and sex are historically understudied factors in biomedical studies even though many complex traits and diseases vary by these factors in their incidence and presentation. As a result, there are massive gaps in our understanding of genes and molecular mechanisms that underlie sex- and age-associated physiology and disease. Hundreds of thousands of publicly-available human transcriptomes capturing gene expression profiles of tissues across the body and subject to various biomedical and clinical factors present an invaluable, yet untapped, opportunity for bridging these gaps. Here, we present a computational framework that leverages these data to infer genome-wide molecular signatures specific to sex and age groups. As the vast majority of these profiles lack age and sex labels, the core idea of our framework is to use the measured expression data to predict missing age/sex metadata and derive the signatures from the predictive models. We first curated ∼30,000 primary samples associated with age and sex information and profiled using microarray and RNA-seq. Then, we used this dataset to infer sex-biased genes within eleven age groups along the human lifespan and then trained machine learning (ML) models to predict these age groups from gene expression values separately within females and males. Specifically, we trained one-vs-rest logistic regression classifiers with elastic-net regularization to classify transcriptomes into age groups. Dataset-level cross validation shows that these ML classifiers are able to discriminate between age groups in a biologically meaningful way in each sex across technologies. Further, these predictive models capture sex-stratified age-group ‘gene signatures’, i.e., the strength and the direction of importance of genes across the genome for each age group in each sex. Enrichment analysis of these gene signatures with prior gene annotations helped in identifying age- and sex-associated multi-tissue and pan-body molecular phenomena (e.g., general immune response, inflammation, metabolism, hormone response). We developed a web-app ( http://mlgenesignatures.org/ ) to visualize our expression dataset, signatures, and enrichment results to make these easily accessible for interested researchers. Overall, we have presented a path for effectively leveraging massive public omics data collections to investigate the molecular basis of age- and sex-differences in physiology and disease. Summary: Hundreds of thousands of publicly-available human transcriptomes capturing gene expression profiles of tissues across the body and subject to various biomedical and clinical factors present an invaluable, yet untapped, opportunity for studying age and sex. We first curated ∼30,000 primary microarray and RNA-seq samples. Then, we used this dataset to infer sex-biased genes within eleven age groups along the human lifespan and trained machine learning models to predict these age groups from gene expression values separately within females and males. These predictive models capture sex-stratified age-group ‘gene signatures’, i.e., the strength and the direction of importance of every gene in each age group in each sex. Enrichment analysis of these gene signatures with prior gene annotations helped identify age- and sex-associated multi-tissue molecular phenomena. A web-app makes our dataset and results easily visualizable. Overall, we have presented a path for effectively leveraging massive public omics data collections to investigate the molecular basis of age- and sex-differences in physiology and disease.
- Open Access
Robust normalization and transformation techniques for constructing gene coexpression networks from RNA-seq data
Background: Constructing gene coexpression networks is a powerful approach for analyzing high-throughput gene expression data towards module identification, gene function prediction, and disease-gene prioritization. While optimal workflows for constructing coexpression networks – including good choices for data pre-processing, normalization, and network transformation – have been developed for microarray-based expression data, such well-tested choices do not exist for RNA-seq data. Almost all studies that compare data processing/normalization methods for RNA-seq focus on the end goal of determining differential gene expression. Results: Here, we present a comprehensive benchmarking and analysis of 30 different workflows, each with a unique set of normalization and network transformation methods, for constructing coexpression networks from RNA-seq datasets. We tested these workflows on both large, homogenous datasets (Genotype-Tissue Expression project) and small, heterogeneous datasets from various labs (submitted to the Sequence Read Archive). We analyzed the workflows in terms of aggregate performance, individual method choices, and the impact of multiple dataset experimental factors. Our results demonstrate that between-sample normalization has the biggest impact, with trimmed mean of M-values or upper quartile normalization producing networks that most accurately recapitulate known tissue-naive and tissue-specific gene functional relationships. Conclusions: Based on this work, we provide concrete recommendations on robust procedures for building an accurate coexpression network from an RNA-seq dataset. In addition, researchers can examine all the results in great detail at https://krishnanlab.github.io/norm_for_RNAseq_coexp to make appropriate choices for coexpression analysis based on the experimental factors of their RNA-seq dataset.
Open AccessRobust normalization and transformation techniques for constructing gene coexpression networks from RNA-seq data
Background: Constructing gene coexpression networks is a powerful approach for analyzing high-throughput gene expression data towards module identification, gene function prediction, and disease-gene prioritization. While optimal workflows for constructing coexpression networks – including good choices for data pre-processing, normalization, and network transformation – have been developed for microarray-based expression data, such well-tested choices do not exist for RNA-seq data. Almost all studies that compare data processing/normalization methods for RNA-seq focus on the end goal of determining differential gene expression. Results: Here, we present a comprehensive benchmarking and analysis of 30 different workflows, each with a unique set of normalization and network transformation methods, for constructing coexpression networks from RNA-seq datasets. We tested these workflows on both large, homogenous datasets (Genotype-Tissue Expression project) and small, heterogeneous datasets from various labs (submitted to the Sequence Read Archive). We analyzed the workflows in terms of aggregate performance, individual method choices, and the impact of multiple dataset experimental factors. Our results demonstrate that between-sample normalization has the biggest impact, with trimmed mean of M-values or upper quartile normalization producing networks that most accurately recapitulate known tissue-naive and tissue-specific gene functional relationships. Conclusions: Based on this work, we provide concrete recommendations on robust procedures for building an accurate coexpression network from an RNA-seq dataset. In addition, researchers can examine all the results in great detail at https://krishnanlab.github.io/norm_for_RNAseq_coexp to make appropriate choices for coexpression analysis based on the experimental factors of their RNA-seq dataset.
- Open Access
- 3 July 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12  (7) , 619
A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
Drug delivery to the brain is highly hindered by the presence of the blood–brain barrier (BBB), which prevents the entry of many potential drugs/biomolecules into the brain. One of the current strategies to achieve gene therapy for neurodegenerative diseases involves direct injection of a viral vector into the brain. There are various disadvantages of viral vectors, including limitations of cargo size and safety concerns. Nanomolecules, such as dendrimers, serve as an excellent alternative to viral delivery. In this study, as proof-of-concept, we used a surface-modified dendrimer complex and delivered large plasmids to cells in vitro and in vivo in healthy rats via intracranial injection. The dendrimers were biodegradable by chemicals found within cells and toxicity assays revealed that the modified dendrimers were much less toxic than unmodified amine-surface dendrimers. As mentioned in our previous publication, these dendrimers with appropriately modified surfaces are safe, can deliver large plasmids to the brain, and can overcome the cargo size limitations associated with viral vectors. The biocompatibility of this dendritic nanomolecule and the ability to finely tune its surface chemistry provides a gene delivery system that could facilitate future in vivo cellular reprograming and other gene therapies.
- 3 July 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12  (7) , 619
Open AccessA Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
Drug delivery to the brain is highly hindered by the presence of the blood–brain barrier (BBB), which prevents the entry of many potential drugs/biomolecules into the brain. One of the current strategies to achieve gene therapy for neurodegenerative diseases involves direct injection of a viral vector into the brain. There are various disadvantages of viral vectors, including limitations of cargo size and safety concerns. Nanomolecules, such as dendrimers, serve as an excellent alternative to viral delivery. In this study, as proof-of-concept, we used a surface-modified dendrimer complex and delivered large plasmids to cells in vitro and in vivo in healthy rats via intracranial injection. The dendrimers were biodegradable by chemicals found within cells and toxicity assays revealed that the modified dendrimers were much less toxic than unmodified amine-surface dendrimers. As mentioned in our previous publication, these dendrimers with appropriately modified surfaces are safe, can deliver large plasmids to the brain, and can overcome the cargo size limitations associated with viral vectors. The biocompatibility of this dendritic nanomolecule and the ability to finely tune its surface chemistry provides a gene delivery system that could facilitate future in vivo cellular reprograming and other gene therapies.
- Open Access
- 1 June 2020
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 36  (11) , 3457-3465
Supervised learning is an accurate method for network-based gene classification
Assigning every human gene to specific functions, diseases and traits is a grand challenge in modern genetics. Key to addressing this challenge are computational methods, such as supervised learning and label propagation, that can leverage molecular interaction networks to predict gene attributes. In spite of being a popular machine-learning technique across fields, supervised learning has been applied only in a few network-based studies for predicting pathway-, phenotype- or disease-associated genes. It is unknown how supervised learning broadly performs across different networks and diverse gene classification tasks, and how it compares to label propagation, the widely benchmarked canonical approach for this problem. In this study, we present a comprehensive benchmarking of supervised learning for network-based gene classification, evaluating this approach and a classic label propagation technique on hundreds of diverse prediction tasks and multiple networks using stringent evaluation schemes. We demonstrate that supervised learning on a gene’s full network connectivity outperforms label propagaton and achieves high prediction accuracy by efficiently capturing local network properties, rivaling label propagation’s appeal for naturally using network topology. We further show that supervised learning on the full network is also superior to learning on node embeddings (derived using node2vec), an increasingly popular approach for concisely representing network connectivity. These results show that supervised learning is an accurate approach for prioritizing genes associated with diverse functions, diseases and traits and should be considered a staple of network-based gene classification workflows. The datasets and the code used to reproduce the results and add new gene classification methods have been made freely available. arjun@msu.edu Supplementary data are available at Bioinformatics online.
- 1 June 2020
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 36  (11) , 3457-3465
Open AccessSupervised learning is an accurate method for network-based gene classification
Assigning every human gene to specific functions, diseases and traits is a grand challenge in modern genetics. Key to addressing this challenge are computational methods, such as supervised learning and label propagation, that can leverage molecular interaction networks to predict gene attributes. In spite of being a popular machine-learning technique across fields, supervised learning has been applied only in a few network-based studies for predicting pathway-, phenotype- or disease-associated genes. It is unknown how supervised learning broadly performs across different networks and diverse gene classification tasks, and how it compares to label propagation, the widely benchmarked canonical approach for this problem. In this study, we present a comprehensive benchmarking of supervised learning for network-based gene classification, evaluating this approach and a classic label propagation technique on hundreds of diverse prediction tasks and multiple networks using stringent evaluation schemes. We demonstrate that supervised learning on a gene’s full network connectivity outperforms label propagaton and achieves high prediction accuracy by efficiently capturing local network properties, rivaling label propagation’s appeal for naturally using network topology. We further show that supervised learning on the full network is also superior to learning on node embeddings (derived using node2vec), an increasingly popular approach for concisely representing network connectivity. These results show that supervised learning is an accurate approach for prioritizing genes associated with diverse functions, diseases and traits and should be considered a staple of network-based gene classification workflows. The datasets and the code used to reproduce the results and add new gene classification methods have been made freely available. arjun@msu.edu Supplementary data are available at Bioinformatics online.
- Open Access
Supervised-learning is an accurate method for network-based gene classification
Background: Assigning every human gene to specific functions, diseases, and traits is a grand challenge in modern genetics. Key to addressing this challenge are computational methods such as supervised-learning and label-propagation that can leverage molecular interaction networks to predict gene attributes. In spite of being a popular machine learning technique across fields, supervised-learning has been applied only in a few network-based studies for predicting pathway-, phenotype-, or disease-associated genes. It is unknown how supervised-learning broadly performs across different networks and diverse gene classification tasks, and how it compares to label-propagation, the widely-benchmarked canonical approach for this problem. Results: In this study, we present a comprehensive benchmarking of supervised-learning for network-based gene classification, evaluating this approach and a state-of-the-art label-propagation technique on hundreds of diverse prediction tasks and multiple networks using stringent evaluation schemes. We demonstrate that supervised-learning on a gene’s full network connectivity outperforms label-propagation and achieves high prediction accuracy by efficiently capturing local network properties, rivaling label-propagation’s appeal for naturally using network topology. We further show that supervised-learning on the full network is also superior to learning on node-embeddings (derived using node2vec ), an increasingly popular approach for concisely representing network connectivity. Conclusion: These results show that supervised-learning is an accurate approach for prioritizing genes associated with diverse functions, diseases, and traits and should be considered a staple of network-based gene classification workflows. The datasets and the code used to reproduce the results and add new gene classification methods have been made freely available. Contact: arjun@msu.edu
Open AccessSupervised-learning is an accurate method for network-based gene classification
Background: Assigning every human gene to specific functions, diseases, and traits is a grand challenge in modern genetics. Key to addressing this challenge are computational methods such as supervised-learning and label-propagation that can leverage molecular interaction networks to predict gene attributes. In spite of being a popular machine learning technique across fields, supervised-learning has been applied only in a few network-based studies for predicting pathway-, phenotype-, or disease-associated genes. It is unknown how supervised-learning broadly performs across different networks and diverse gene classification tasks, and how it compares to label-propagation, the widely-benchmarked canonical approach for this problem. Results: In this study, we present a comprehensive benchmarking of supervised-learning for network-based gene classification, evaluating this approach and a state-of-the-art label-propagation technique on hundreds of diverse prediction tasks and multiple networks using stringent evaluation schemes. We demonstrate that supervised-learning on a gene’s full network connectivity outperforms label-propagation and achieves high prediction accuracy by efficiently capturing local network properties, rivaling label-propagation’s appeal for naturally using network topology. We further show that supervised-learning on the full network is also superior to learning on node-embeddings (derived using node2vec ), an increasingly popular approach for concisely representing network connectivity. Conclusion: These results show that supervised-learning is an accurate approach for prioritizing genes associated with diverse functions, diseases, and traits and should be considered a staple of network-based gene classification workflows. The datasets and the code used to reproduce the results and add new gene classification methods have been made freely available. Contact: arjun@msu.edu